CI

$263.47

Post-MarketAs of Mar 17, 8:00 PM UTC

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States.

Historical Price

Price (Line)
Synthesizing Whystock Narrative...
Loading Financials...

Peer Comparison

JNJUNHPFE

Whystock Valuation Model

Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$263.47
Potential Upside
77.1%
Whystock Fair Value$466.57
Price
UndervaluedFair ValueOvervalued

Fundamentals

SectorHealthcare
IndustryHealthcare Plans

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare. The Evernorth Health Services segment includ...

Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$70.38B
P/E Ratio
Value territory. Trading at a high yield relative to earnings.
11.87
Beta
Defensive asset. Lower volatility than the S&P 500.
0.23
Div Yield
Strong income play. Yield provides a meaningful total return floor.
233.00%
ROIC
Elite ROE. Management converts capital into profit efficiently.
15.13%
Quick Ratio
Tight liquidity. Monitor cash flow carefully against debt.
0.67

Recent News

Insider Monkey
Mar 16, 2026

Bernstein Upgrades The Cigna Group (CI) From “Market Perform” to “Outperform”

The Cigna Group (NYSE:CI) stands among the 11 best very cheap stocks to buy according to billionaires. On March 12, 2026, The Cigna Group (NYSE:CI) drew attention from analysts at Bernstein. The firm’s analysts expect the stock’s multiple to increase over time, citing the combination of the Pharmacy Benefit Manager reform bill and the FTC […]

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Simply Wall St.
Mar 13, 2026

The Bull Case For Cigna Group (CI) Could Change Following CEO Succession To Brian Evanko – Learn Why

The Cigna Group has announced that long-time CEO David M. Cordani will retire from the role on July 1, 2026, transitioning to executive chair while current president and COO Brian Evanko becomes chief executive officer and joins the board. This planned leadership handover, featuring a successor with deep experience across Cigna Healthcare, Evernorth Health Services, and finance, signals an emphasis on continuity in data-driven, technology-enabled healthcare services. We’ll now examine how...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Simply Wall St.
Mar 13, 2026

Is Cigna Group (CI) Offering Value After Recent Share Price Weakness?

If you are wondering whether Cigna Group is offering good value at its current share price, this breakdown will help you see how the market is pricing the stock today. The share price most recently closed at US$265.88, with returns of a 5.5% decline over 7 days, a 7.6% decline over 30 days, a 4.7% decline year to date, a 13.0% decline over 1 year, 2.5% over 3 years and 19.3% over 5 years. Taken together, these figures give a mixed picture of how investors have been reassessing the company...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Zacks
Mar 13, 2026

Cigna Stock Trades Below Industry P/E: Is It Worth Holding Now?

CI trades below industry P/E as Evernorth growth, steady earnings beats and buybacks support outlook, though rising medical costs and debt remain key risks.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
24/7 Wall St.
Mar 13, 2026

CVS vs Cigna: Which Healthcare Giant Belongs in Your Retirement Portfolio?

CVS Health (NYSE: CVS) and Cigna Group (NYSE: CI) are both major players in American healthcare. For retirement investors choosing between them, the key question is: do you prefer stability and income at a discount, or stronger earnings quality and capital discipline at an even steeper discount? Valuation Both stocks are cheap by historical healthcare ... CVS vs Cigna: Which Healthcare Giant Belongs in Your Retirement Portfolio?

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.